OPTIMISTIC: Observational Prolonged Trial in Myotonic Dystrophy Type 1 to Improve QoL-Standards, a Target Identification Collaboration (joint with Concentris Research Management GmbH,Radboud University Nijmegen-Holland, Newcastle University, Munich University, University of Paris Est Creteil, Glasgow University and Industrial Partner)

StatusFinished
Effective start/end date1/11/1230/04/17

Funding

  • COMMISSION OF THE EUROPEAN COMMUNITIES (OPTIMISTIC: 305697): £192,955.00